Skip to content

Wednesday, 4 November 2026

Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript

From The Motley Fool 3 Nov 2026, 05:08 UTC 1 min read

Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.

Full story

Continue reading this story on The Motley Fool, the publisher that reported it.

Read the full story at The Motley Fool ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all

Business

Greg Abel Just Plowed Another $27 Million Into One of Berkshire Hathaway's Top 20 Holdings That's Up 62% This Year and Has a 3.3% Dividend Yield

20 min ago

Business

Was Elon Musk the Midterms’ Biggest Loser? What It Means for Tesla and SpaceX Investors

24 min ago 3 sources

Business

Salesforce Stock Has Only Done This Twice Before. Here's What History Suggests Happens Next.

28 min ago

Business

Waymo confirms it will split with Uber in January 2028

46 min ago

Business

‘You Can See Everything’ is getting an outer space release and it hasn’t even come out in Europe yet

48 min ago

Business

Is Broadcom Stock a Buy Now?

58 min ago